Navigation Links
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Date:2/26/2009

nt portfolios by taking cash for their shares at a time when cash provides certainty and stability," said Kevin Buchi, chief financial officer at Cephalon. "We are better equipped to take Arana's lead compound, ART621, through clinical development and, pending the success of clinical trials, to international markets."

To support its bid, Cephalon has acquired a shareholding in Arana, representing an ownership position of approximately 19.9 percent of the total issued share capital of Arana. The purchase price of the shares was A$1.40 per share. Cephalon has acquired this stake from Arana's two largest shareholders, Start-up Australia Ventures Pty Ltd and Rockwell Securities Limited.

Cephalon's offer will be subject to certain basic conditions (outlined in Appendix A), including a 50.1 percent minimum acceptance condition.

Cephalon is well advanced in the preparation of its Bidder's Statement, and expects the offer will be open for acceptance by mid-March.

Arana is a biopharmaceutical company focused on developing next generation antibody based drugs that will improve the lives of patients with inflammatory diseases and cancer. The company's lead compound, ART621, is a new generation tumor necrosis factor (TNF ) alpha blocker in development for patients with inflammatory diseases. Arana has a strong patent portfolio related to anti-TNF alpha antibodies and receives royalties from Abbott Laboratories and Johnson & Johnson, the makers of HUMIRA(R) and REMICADE(R), respectively. Cephalon expects these royalties largely to offset costs of development in the near term. Therefore, Cephalon is making no change to its 2009 adjusted net income guidance.

"Arana would bolster our burgeoning inflammatory disease pipeline as well as our oncology pipeline," said Frank Baldino, Jr., Ph.D., chairman and CEO of Cephalon. "Arana has an established protein engineering technology platform
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... ... On May 30th, 2015, Best Drug Rehabilitation, a results-based substance abuse treatment center ... concert in Mendon, IL. Held in the Show Barn at the Adams County Fairgrounds, ... in the underfunded local school districts of Mendon at neighboring Quincy, IL. Now in ...
(Date:8/28/2015)... ... ... Frequentz ” was featured on NewsWatch as part of its monthly AppWatch, which takes ... and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the app ... from beginning to end. , Businesses benefit greatly from having the ability to track ...
(Date:8/28/2015)... ... ... Medical Solutions, one of the nation’s largest travel nurse staffing companies, has ... Healthcare and will be honored at an awards dinner in Chicago on Wednesday, ... to Work in Healthcare program recognizes outstanding employers in the healthcare industry nationwide. Modern ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... Dr. Gregory ... such as radiating pain resulting in shoulder pain, hip pain, neck pain, ... in Civil Engineering from the University of Illinois, and then went on to earn ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... Northridge ... on Zoom teeth whitening. For just $199, patients can currently receive a one hour ... in-office teeth whitening procedures, but it includes a number of unique features that can ...
Breaking Medicine News(10 mins):Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... FRANCISCO, Nov. 24 In preparation for its January ... San Francisco,s highly regarded Institute on Aging (IOA). , ... innovative, nonprofit, membership-based, "aging-in-place",program designed to help older adults ... homes, apartments, and neighborhoods as long as they wish ...
... -- A new study involving health care systems in 21 ... such common pressures as rising costs and aging populations -- ... of these systems because of the history and traditions that ... online issue of the Journal of Health and Social ...
... ) is pleased to invite you to listen to its 2009 guidance conference call, ... a.m. ET. , , , What: ... When: December 18, 2008, ... , , , Covance, with headquarters in Princeton, New ...
... Novo-TTF device in vitro and in a pilot ... efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed ... with standard chemotherapy, the Novo-TTF, a non-invasive medical ... to destroy cancer cells, enhanced the anti-tumor effects ...
... if the blood was less than nine days old, study ... of fresh red blood cells -- emphasis on the word ... and improve their odds of long-term survival, a new report ... Anesthesiology , is based on research into the mystery ...
... will be,participating in the fifth year of the ... which will run nationwide in CVS/pharmacy,locations through December ... add $1 to their purchase at the register ... of the world,s premier centers for the,research and ...
Cached Medicine News:Health News:Institute on Aging Collaborates With New Program San Francisco Village 2Health News:Health care reform: No revolution in sight 2Health News:Health care reform: No revolution in sight 3Health News:Studies show novel device may enhance chemotherapy treatment in brain tumors 2Health News:Studies show novel device may enhance chemotherapy treatment in brain tumors 3Health News:'Fresh' Transfusions Improve Odds for Cancer Patients After Surgery 2Health News:CVS/pharmacy Raising Funds for the St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign to Support Expanded Rehabilitation Services Center 2Health News:CVS/pharmacy Raising Funds for the St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign to Support Expanded Rehabilitation Services Center 3
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... 27, 2015  A recent study by Feucht ... compared the Arthrosurface HemiCAP® Wave implant, which is ... "onlay" design implant for isolated patellofemoral disease. While ... and pain scores, none of the patients in ... However, 53% of the patients in the "onlay" ...
(Date:8/27/2015)... , August 27, 2015 According to a ... Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), ... to 2020", published by MarketsandMarkets, the Medical Lifting Sling Market is ... Million in 2015, at a CAGR of 11.4 % from 2015 ... ma rket data T ables and ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
LEMAIRE stapes are stainless steel staples indicated for ligament fixation....
... ligament surgery account for ... of hindfoot and mid-foot ... most common procedure. The ... allow very effective stabilization ...
The Orengo staple is an oval staple, with thicker and longer legs (25 mm). It is then more especially bound to be used onto thick bones. The design of its stapler makes it more difficult to use und...
The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
Medicine Products: